Neuregulin 1 and Susceptibility to Schizophrenia

American Journal of Human Genetics

Volumn 71, Issue 4, 2002, Pages 877-892

  Stefansson, Hreinn ^a,b   Sigurdsson, Engilbert ^b   Steinthorsdottir, Valgerdur ^c   Bjornsdottir, Soley ^d   Sigmundsson, Thordur ^e   Ghosh, Shyamali ^f   Brynjolfsson, Jon ^g   Gunnarsdottir, Steinunn ^h   Ivarsson, Omar ⁱ   Chou, Thomas T ^a   Hjaltason, Omar ^a   Birgisdottir, Birgitta ^b   Jonsson, Helgi ^a   Gudnadottir, Vala G ^b   Gudmundsdottir, Elsa ^c   Bjornsson, Asgeir ^d   Ingvarsson, Brynjolfur ^e   Ingason, Andres ^f   Sigfusson, Sigmundur ^g   Hardardottir, Hronn ^h   Harvey, Richard P ⁱ   Lai, Donna ^a   Zhou, Mingdong ^a   Brunner, Daniela ^b   Mutel, Vincent ^a   Gonzalo, Acuna ^b   Lemke, Greg ^c   Sainz, Jesus ^d   Johannesson, Gardar ^e   Andresson, Thorkell ^f   Gudbjartsson, Daniel ^g   Manolescu, Andrei ^h   Frigge, Michael L ⁱ   Gurney, Mark E ^a   Kong, Augustine ^b   Gulcher, Jeffrey R ^b   Petursson, Hannes ^a   Stefansson, Kari ^b   more..

^a DECODE GENETICS   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c Akureyri Hospital   (Iceland)

^d VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f Zensun Sci and Tech   (China)

^g PSYCHOGENICS INC   (United States)

^h F HOFFMANN LA ROCHE LTD   (Switzerland)

ⁱ SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 4; NEU DIFFERENTIATION FACTOR;

ANIMAL; ARTICLE; C57BL MOUSE; CHROMOSOME 8; CHROMOSOME MAP; DISEASE MODEL; FEMALE; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HUMAN; MALE; MOLECULAR GENETICS; MOUSE; SCHIZOPHRENIA;

ANIMALS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 8; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NEUREGULIN-1; RECEPTOR, EPIDERMAL GROWTH FACTOR; SCHIZOPHRENIA;

EID: 0013375948     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/342734     Document Type: Article

References (57)

1. Bilder RM, Corcoran R, Frith CD (1996) Neuropsychology and neurophysiology in schizophrenia. Curr Opin Psychiatry 9:57-62
2. Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, Thornquist M, et al (1998) Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 20:70-73
3. Braff DL, Geyer MA (1990) Sensorimotor gating and schizophrenia: human and animal model studies. Arch Gen Psychiatry 47:181-188
4. Brzustowicz LM, Honer WG, Chow EW, Little D, Hogan J, Hodgkinson K, Bassett AS ( 1999) Linkage of familial schizophrenia to chromosome 13q32. Am J Hum Genet 65:1096-1103
5. + channels in parasympathetic neurons. Proc Natl Acad Sci USA 98:2832-2836
6. Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR, Davies NJ, Venturi P, Jones LA, Lewis SW, Sham PC, Gottesman II, Farmer AE, McGuffin P, Reveley AM, Murray RM (1999) Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry 56:162-168
7. Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease. Trends Neurosci 13:272-276
8. Chen X, Levine L, Kwok PY (1999) Fluorescence polarization in homogeneous nucleic acid analysis. Genome Res 9:492-498
9. Chu GC, Moscoso LM, Sliwkowski MX, Merlie JP (1995) Regulation of the acetylcholine receptor subunit gene by recombinant ARIA: an in vitro model for transynaptic gene regulation. Neuron 14:329-339
10. Clayton D, Jones H (1999) Transmission/disequilibrium tests for extended marker haplotypes. Am J Hum Genet 65:1161-1169
11. Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481-483
12. Dempster AP, Laird NM, Rubin DB (1977) Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc B 39:1-38
13. Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K, Arnold K, Ruano G, Liggett SB (2000) Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Nad Acad Sci USA 97:10483-10488
14. Erickson SL, O'Shea KS, Ghaboosi N, Loverro L, Frantz G, Bauer M, Lu LH, Moore MW (1997) ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice. Development 124:4999-5011
15. Excoffier L, Slatkin M (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12:921-927
16. Fischbach GD, Rosen KM (1997) ARIA: a neuromuscular junction neuregulin. Annu Rev Neurosci 20:429-458
17. Freedman R, Hall M, Adler LE, Leonard S (1995) Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry 38:22-33
18. Gao XM, Sakai K, Roberts RC, Conley RR, Dean B, Tamminga CA (2000) lonotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am J Psychiatry 157:1141-1149
19. Garcia RA, Vasudevan K, Buonanno A (2000) The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses. Proc Natl Acad Sci USA 97:3596-3601
20. Gassmann M, Casagranda F, Orioli D, Simon H, Lai C, Klein R, Lemke G (1995) Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 378:390-394
21. Gerber DJ, Sotnikova TD, Gainetdinov RR, Huang SY, Caron MG, Tonegawa S (2001) Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc Natl Acad Sci USA 98:15312-15317
22. Gerlai R, Pisacane P, Erickson S (2000) Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks. Behav Brain Res 109:219-227
23. Glickstein SB, Schmauss C (2001) Dopamine receptor functions: lessions from knockout mice. Pharmacol Ther 91:63-83
24. Goff DC, Coyle JT (2001) The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 158:1367-1377
25. Goring HH, Terwilliger JD, Blangero J (2001) Large upward bias in estimation of locus-specific effects from genomewide scans. Am J Hum Genet 69:1357-1369
26. Gretarsdottir S, Sveinbjornsdottir S, Jonsson HH, Jakobsson F, Einarsdottir E, Agnarsson U, Shkolny D, et al (2002) Localization of a susceptibility gene for common forms of stroke to 5ql2. Am J Hum Genet 70:593-603
27. Gudbjartsson DF, Jonasson K, Frigge ML, Kong A (2000) Allegro, a new computer program for multipoint linkage analysis. Nat Genet 25:12-13
28. Gulcher JR, Kristjansson K, Gudbjartsson H, Stefansson K (2000) Protection of privacy by third-party encryption in genetic research in Iceland. Eur J Hum Genet 8:739-742
29. Gurling HM, Kalsi G, Brynjolfson J, Sigmundsson T, Sherrington R, Mankoo BS, Read T, Murphy P, Blaveri E, McQuillin A, Petursson H, Curtis D (2001) Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes Iq32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20ql2.111.23. Am J Hum Genet 68:661-673
30. Hawley M, Kidd K (1995) HAPLO: a program using the EM algorithm to estimate the frequencies of multi-site haplotypes. J Hered 86:409-411
31. Holt DJ, Herman MM, Hyde TM, Kleinman JE, Sinton CM, German DC, Hersh LB, Graybiel AM, Saper CB (1999) Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia. Neuroscience 94:21-31
32. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, et al (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nature Genet 26:163-175
33. Huang YZ, Won S, Ali DW, Wang Q, Tanowitz M, Du QS, Pelkey KA, Yang DJ, Xiong WC, Salter MW, Mei L (2000) Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron 26:443-455
34. Ibrahim HM, Hogg AJ Jr, Healy DJ, Haroutunian V, Davis KL, Meador-Woodruff JH (2000) lonotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. Am J Psychiatry 157:1811-1823
35. Kaufmann CA, Suarez B, Malaspina D, Pepple J, Svrakic D, Market PD, Meyer J, Zambuto CT, Schmitt K, Matise TC, Harkavy Friedman JM, Hampe C, Lee H, Shore D, Wynne D, Faraone SV, Tsuang MT, Cloninger CR (1998) NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees. Am J Med Genet 81:282-289
36. Kendler KS, MacLean CJ; O'Neill FA, Burke J, Murphy B, Duke F, Shinkwin R, Easter SM, Webb BT, Zhang J, Walsh D, Straub RE (1996) Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families. Am J Psychiatry 153:1534-1540
37. Kong A, Cox NJ (1997) Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 61:1179-1188
38. Kong A, Gudbjartsson DF, Sainz J, Jonsdottir GM, Gudjonsson SA, Richardsson B, Sigurdardottir S, Barnard J, Hallbeck B, Masson G, Shlien A, Palsson ST, Frigge ML, Thorgeirsson TE, Gulcher JR, Stefansson K (2002) A highresolution recombination map of the human genome. Nat Genet 31:241-247
39. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander, ES (1996) Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 58:1347-1363
40. Lau LF, Huganir RL (1995) Differential tyrosine phosphorylation of N-methyl-D-aspartate receptor subunits. J Biol Chem 270:20036-20041
41. Levinson DF, Wildenauer DB, Schwab SG, Albus M, Hallmayer J, Lerer B, Maier W, et al (1996) Additional support for schizophrenia linkage on chromosomes 6 and 8: a multicenter study. Am J Med Genet 67:580-594
42. Liddle PF, Carpenter WT, Crow T ( 1994 ) Syndromes of schizophrenia: classic literature. Br J Psychiatry 165:721-727
43. Liu X, Hwang H, Cao L, Buckland M, Cunningham A, Chen J, Chien KR, Graham RM, Zhou M (1998) Domain-specific gene disruption reveals critical regulation of neuregulin signaling by its cytoplasmic tail. Proc Natl Acad Sci USA 95:13024-13029
44. Long JC, Williams RC, Urbanek M (1995) An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet 56:799-810
45. Mohn AR, Gainetdinov RR, Caron MG, Koller BH (1999) Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98:427-436
46. O'Donovan MC, Owen MJ (1999) Candidate-gene association studies of schizophrenia. Am J Hum Genet 65:587-592
47. O'Neill MF, Shaw G (1999) Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice. Psychopharmacology 145:237-250
48. Ozaki M, Sasner M, Yano R, Lu HS, Buonanno A (1997) Neuregulin-beta induces expression of an NMDA-receptor subunit. Nature 390:691-694
49. Pulver AE, Lasseter VK, Kasch L, Wolyniec P, Nestadt G, Blouin JL, Kimberland M, Babb R, Vourlis S, Chen HM, Lalioti M, Morris MA, Karayiorgou M, Ott J, Meyers D, Antonarakis SE, Housman D, Kazazian HH (1995) Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Am J Med Genet 60:252-260
50. Risch N (1990) Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 46:222-228
51. Shaw SH, Kelly M, Smith AB, Shields G, Hopkins PJ, Loftus J, Laval SH, Vita A, De Hert M, Cardon LR, Crow TJ, Sherrington R, DeLisi LE (1998) A genome-wide search for schizophrenia susceptibility genes. Am J Med Genet 81:364-376
52. Spielman RS, McGinnis RE, Ewens WJ (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516
53. Spitzer R, Endicott J (eds) (1977) The schedule for affective disorders and schizophrenia, lifetime version. 3rd ed. New York State Psychiatric Institute, New York
54. Spitzer RL, Endicott J, Robins E (1978) Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 35:773-782
55. Steiner H, Blum M, Kitai ST, Fedi P (1999) Differential expression of ErbB3 and ErbB4 neuregulin receptors in do-pamine neurons and forebrain areas of the adult rat. Exp Neurol 159:494-503
56. Tsuang MT, Stone WS, Faraone SV (2001) Genes, environment and schizophrenia. Br J Psychiatry Suppl 40:18-24
57. Wang JY, Miller SJ, Falls DL (2001) The N-terminal region of neuregulin isoforms determines the accumulation of cell surface and released neuregulin ectodomain. J Biol Chem 276:2841-2851